Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Reviews Rheumatology (4)
Nature Reviews Endocrinology (2)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Comments & Opinion (3)
Reviews (2)
News & Views (1)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Diseases
Health care
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–6 of 6 results

Advanced filters: Author: E Michael Lewiecki Clear advanced filters

New targets for intervention in the treatment of postmenopausal osteoporosis

Advances in our understanding of bone remodelling have revealed a number of potential therapeutic targets in metabolic bone disorders such as postmenopausal osteoporosis. In this Review, Dr Michael Lewiecki describes these novel targets and the relevant experimental therapies that are at various stages of clinical development.

E. Michael Lewiecki
Reviews20 Sept 2011
Nature Reviews Rheumatology

Volume: 7, P: 631-638
Is denosumab better than alendronate in the treatment of osteoporosis?

E Michael Lewiecki
Comments & Opinion17 Dec 2008
Nature Clinical Practice Rheumatology

Volume: 5, P: 72-73
Pharmacologic therapy to reduce fracture risk: comment on the clinical practice guidelines of the ACP

E Michael Lewiecki
Comments & Opinion01 Mar 2009
Nature Reviews Rheumatology

Volume: 5, P: 120-121
Common mistakes in the clinical use of bone mineral density testing

Bone mineral density testing is used to diagnose osteoporosis, assess the associated fracture risk and monitor changes over time. In this Review, the authors describe the common technical and interpretation errors that are encountered in the clinical use of bone densitometry, with a primary focus on DXA.

E Michael Lewiecki
Nancy E Lane
Reviews21 Oct 2008
Nature Clinical Practice Rheumatology

Volume: 4, P: 667-674
Is alendronate therapy cost-effective for postmenopausal osteopenia?

E Michael Lewiecki
Comments & Opinion01 Dec 2005
Nature Clinical Practice Endocrinology & Metabolism

Volume: 1, P: 74-75
Using FRAX^® wisely: lessons from Switzerland and beyond

The assessment of fracture risk with currently available clinical tools can aid the identification of patients who require further evaluation and treatment to reduce fracture risk. Optimal use of these tools requires good clinical judgment and a thorough understanding of their benefits and limitations.

E. Michael Lewiecki
News & Views01 Mar 2010
Nature Reviews Endocrinology

Volume: 6, P: 126-128

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Filter By:

New targets for intervention in the treatment of postmenopausal osteoporosis

Is denosumab better than alendronate in the treatment of osteoporosis?

Pharmacologic therapy to reduce fracture risk: comment on the clinical practice guidelines of the ACP

Common mistakes in the clinical use of bone mineral density testing

Is alendronate therapy cost-effective for postmenopausal osteopenia?

Using FRAX® wisely: lessons from Switzerland and beyond

Search

Quick links

Using FRAX^® wisely: lessons from Switzerland and beyond